Marton Laurence 4
4 · RenovoRx, Inc. · Filed Oct 3, 2025
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Marton Laurence
Director
Transactions
- Award
Stock Options (right to buy)
2025-10-01+47,640→ 47,640 totalExercise: $1.34Exp: 2035-10-01→ Common Stock (47,640 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2025.